← Open Payments lookup

JENNIFER WOODBURN: Open Payments

NPI 1003339268 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$743 in 20 payments from 9 companies in 2025. Trend: 2023 $236 · 2024 $445 · 2025 $743

Food & beverage: $743
CompanyPaymentsAmount
Amgen Inc.3$348
E.R. Squibb & Sons, L.L.C.4$82
Medtronic, Inc.2$62
Novartis Pharmaceuticals Corporation3$56
Novo Nordisk Inc2$50
AstraZeneca Pharmaceuticals LP3$50
BridgeBio Pharma, Inc.1$48
PFIZER INC.1$25
Alnylam Pharmaceuticals Inc.1$23

Products named: REPATHA, CAMZYOS, LEQVIO, Wegovy, FARXIGA, Attruby, COREVALVE EVOLUT R, VYNDAQEL.

Industry payments across ID — which companies pay providers there.